U.S. markets closed

  • S&P 500

    3,585.15
    +48.14 (+1.36%)
     

  • Dow 30

    29,479.81
    +399.64 (+1.37%)
     

  • Nasdaq

    11,829.29
    +119.70 (+1.02%)
     

  • Russell 2000

    1,744.04
    +35.57 (+2.08%)
     

  • Crude Oil

    40.12
    -1.00 (-2.43%)
     

  • Gold

    1,888.20
    +14.90 (+0.80%)
     

  • Silver

    24.76
    +0.45 (+1.87%)
     

  • EUR/USD

    1.1837
    +0.0027 (+0.22%)
     

  • 10-Yr Bond

    0.8930
    +0.0080 (+0.90%)
     

  • GBP/USD

    1.3201
    +0.0083 (+0.64%)
     

  • USD/JPY

    104.6200
    -0.4790 (-0.46%)
     

  • BTC-USD

    15,934.13
    -109.20 (-0.68%)
     

  • CMC Crypto 200

    315.08
    +2.21 (+0.71%)
     

  • FTSE 100

    6,316.39
    -22.55 (-0.36%)
     

  • Nikkei 225

    25,385.87
    -135.01 (-0.53%)
     

Nio Stock Reverses Sharply

Nio reversed lower Friday as Citron issued a sell rating. EV stocks have been running. Far extended from averages.

Latest Stories

  • Costco selling $17.5K private jet membership that lasts 1 year

    Costco sells a one-year membership to Wheels Up, a private aviation company, for $17,499.99.

  • Barron's Picks And Pans: Alibaba, Intel, Target, Visa And More

    * This weekend's Barron's cover offers a low-risk strategy for investors optimistic about an ecomomic recovery. * Other featured articles discuss what a COVID-19 vaccine would mean for the stock market and how it could shake up the pharmaceutical industry. * Also, the prospects for semiconductor stocks, a leading retailer, a financial services giant and more."A Low-Risk Strategy for Those Optimistic About a Recovery" by Daren Fonda suggests that small companies typically outperform over the long term, even more so at the beginning of an economic rebound. With a coronavirus vaccine on the horizon, Barron's believes Acme United Corporation (NYSE: ACU) is among the small cap stocks worth a look.Max A. Cherney's "Intel Can Shine Again" looks at how repeated manufacturing delays have dented the reputation of chip giant Intel Corporation (NASDAQ: INTC). In addition, Apple now has ditched Intel's products. Discover why Barron's thinks the stock is down but not out.In "A Covid Vaccine Is Coming. Here's What It Means for the Stock Market," Andrew Bary makes the case that after years of disappointment, a rotation into value-oriented investments from growth could gain traction. See why the likes of Barrick Gold Corp (NYSE: GOLD) could be poised to climb as well.Semiconductor demand is surging, even as mergers reshape the industry. So says "5 Semiconductor Stocks With Stellar Prospects" by Leslie P. Norton. Find out how to play the next growth spurt and whether NVIDIA Corporation (NASDAQ: NVDA) and Teradyne, Inc. (NASDAQ: TER) are among the bargains now.In Bill Alpert's "Covid Vaccine Could Be a Drug Industry Game Changer," see how promising vaccine news lifted hopes that mRNA technology would be validated and speed other products to market. Find out what could this mean for AstraZeneca plc (NYSE: AZN), GlaxoSmithKline plc (NYSE: GSK) and others."Target Is Booming During the Pandemic. Why the Stock Still Looks Undervalued" by Teresa Rivas discusses why, even though Target Corporation (NASDAQ: TGT) is classified as a big-box retailer, these days it looks more like a department store than any department store. Plus, what to expect from this week's earnings report.See also: Benzinga's Bulls And Bears Of The Week: Apple, Disney, Tesla And MoreCheck out how Micron Technology, Inc. (NASDAQ: MU), the biggest pure play bet on memory chips, also could be a play on multiple hot themes, including 5G, electric vehicles, data center growth and even the end of the pandemic. This, according to Eric J. Savitz's "It's Time to Put Aside the Bad Memories of Micron's Stock."In "Pandemic or Not, Visa Remains a Growth Stock Stalking Its Biggest Rival, Cash," Jack Hough focuses on how, despite reduced spending during the pandemic, Visa Inc (NYSE: V) has seen greater adoption as consumers eschew cash. That should pay dividends after the crisis is over, according to this article.Reshma Kapadia's "Alibaba Joins the Ranks of Internet Giants Scorched by Regulators" says China has joined the United States and Europe in scrutinizing the big internet platforms whose shares have soared amid the pandemic. It talks about the case of Alibaba Group Holding Ltd (NYSE: BABA) and the blow that befell its fintech affiliate, Ant Group.Also in this week's Barron's: * What is next for the Consumer Financial Protection Bureau * Why the U.S. election bodes well for tech * Why to expect more ESG activism and SPACs in 2021 * Whether investors can predict special dividends * How to play the value stock boomlet while it lasts * Whether the stock market needs tech to hit new records * ETFs poised to benefit from a retail rebound * What the end of Moore's law means for investors and the economy * Why the $9 billion U.S. Postal Service loss matters * What to expect from the coming retail earnings reportsAt the time of this writing, the author had no position in the mentioned equities.Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.See more from Benzinga * Click here for options trades from Benzinga * Last Week's Notable Insider Buys: Kraft, IBM, Vertex And More * Benzinga's Bulls And Bears Of The Week: Apple, Disney, Tesla And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Simon Property gives up on four struggling malls. Why more could follow

    The largest retail REIT and mall owner in the U.S. is giving lenders on several of its shopping centers an early Christmas present: the keys back.

  • Many boomers still own too much stock: Fidelity

    According to Fidelity, many of its boomer 401(k) and IRA holders saving for retirement hold way too much stock for their age profile.

  • Chinese Electric Car Stocks Rally Comes To Screeching Halt As Short Seller Warns

    The huge rally in China electric car stocks came to a screeching halt Friday after short seller Citron Research targeted Nio.

  • 3 Big Dividend Stocks Yielding at Least 10%; Analysts Say ‘Buy’

    Markets continued their upward trend this week, gaining ground since the November 3 vote. There is an optimistic view that politics will settle into a more normal pattern with a new Administration. Even so, investors have been wary this past autumn – as there is plenty to be wary about. The coronavirus has started a comeback with the advent of cooler weather, and the political uncertainty that surrounded the election has left the status of further economic stimulus packages in limbo.It’s times like these that investors start taking a renewed interest in dividend stocks. These are the classic defensive stocks, and for good reason: a reliable dividend keeps the income flowing, no matter what the markets do. Wall Street analysts have chimed in – and they are recommending high-yield dividend stocks for investors looking to find protection for their portfolio. Here, we’ll take a look at three stocks that fit a profile: a Strong Buy rating from the analyst community, and a dividend yield that gives at least 10%.Stellus Capital (SCM)Stellus Capital offers capital solutions (read: debt financing) for companies in the lower mid-market range. These are companies that may have difficulty accessing capital through large banks; Stellus shoulders the higher risk as an investment opportunity. The capital company’s portfolio includes 67 companies, $1.6 billion in assets under management, and over $6 billion in total funds invested.Stellus has been raising its dividend payment this year. The next dividend has already been declared for December, and shows an effective increase to 31 cents per common share. This comes from combining the regular 25 cent payment with a special 6-cent dividend, and after the company paid out 25 cents per share in the previous two quarters. Counting the regular dividend, the payment annualizes to $1 per common share, and gives a yield of 10.91%.Writing from Raymond James, analyst Robert Dodd says, “Core earnings covered the base dividend in 3Q20, and a strong spillover position should cushion the dividend in 2021. We continue to view the risk /reward attractively."The analyst added, "The SCM pipeline looks robust, with ~10 portfolio companies going through various stages of due diligence. Repayments in 4Q20 could be as high as $30M - with a modest positive impact to NAV from exits above fair value marks at 3Q20.”To this end, Dodd rates SCM shares an Outperform (i.e. Buy) along with a $11 price target. This figure implies a 17% upside from current levels. (To watch Dodd’s track record, click here)Overall, Stellus’ Strong Buy analyst consensus rating is based on 4 reviews, including 3 Buys and 1 Hold. The stock is selling for $9.43 and its average price target of $10.17 suggests it has a one-year upside potential of ~8%. (See SCM stock analysis on TipRanks)WhiteHorse Finance (WHF)Next up is WhiteHorse Finance, another BDC. WhiteHorse’s focus is on small-cap companies, valued at $50 million to $350 million, and WHF’s investments are typically in the $10 million to $50 million range. WhiteHorse’s portfolio totals more than $595 million.A better outlook for the future, based on earnings recovery, has given a firm foundation to dividend payments, and WhiteHorse has kept up its 35.5 cents regular dividend. Combined with a 12.5 cent special dividend, this makes the most recent payment 48 cents per common share. The yield is a sky-high 12.29%.Oppenheimer analyst Chris Kotowski is upbeat about WhiteHorse, noting “WHF reported 3Q20 core net investment income (NII) of $0.38/share versus our $0.32 estimate and consensus' $0.29E. The bottom line was boosted by an interest recovery, but what encouraged us most was both growth and improvement in asset quality. $58.3M of funding activity was only partially offset by only $26.5M of repayments, driving ~8.8% linked-quarter growth in investments alongside mark appreciation."The 5-star analyst added, "Management seemed optimistic about the outlook for loan growth, saying that it was perhaps the best environment they had seen since 2012–2013, and they clearly have the capacity to put capital to work. The current gross leverage of 0.94x (and net 0.87x) sits below management's 1.00–1.25x target leverage, leaving ample room for growth in coming quarters amidst a strong investment pipeline."As a result, Kotowski gives the stock an Outperform (i.e. Buy) rating, and his $15 price target implies a robust 29% upside for the year ahead. (To watch Kotowski’s track record, click here)Overall, WhiteHorse has a unanimous Strong Buy analyst consensus rating, with 3 buy-side reviews on record. The stock is currently priced at $11.65 and its $13.25 average price target suggests it has a one-year upside of 14%. (See WHF stock analysis on TipRanks)Capital Southwest Corporation (CSWC)Last but not least is Capital Southwest, another Texas-based company in the business development sector. CSWC focuses on lending and credit options for mid-market companies. Capital Southwest boasts a portfolio featuring $664 million invested into 69 companies, and has over $150 million in liquidity available.Revenues have been recovering since going negative in Q1, at the height of the corona crisis. Sequential gains in both Q1 and Q2 have brought quarterly revenues to $21 million, while earnings in Q3 showed a strong spike to 45 cents per share, the highest value in over two years.Rising earnings have allowed Capital Southwest to keep up its history of reliable dividend payments. The company raised its dividend going into 2020, and has maintained the 51-cent payment all year. The 10.5% yield is more than 4x higher than the average found among financial sector peer companies, bringing CSWC to the attention of dividend investors.Among CSWC's fans is JMP analyst Devin Ryan, who rates the stock a Buy and gives it a $17 price target. (To watch Ryan's track record, click here)"Overall, we think results for the quarter were strong and that Capital Southwest is one of the most attractive ways to gain exposure to lower-middle-market direct originations. We highlight improving credit quality, strong portfolio growth, a solid pipeline of deal flow, sustainable core/supplemental dividends and management’s focus on expenses as reasons we think the stock is positioned to outperform," Ryan opined.All in all, CSWC has a Strong Buy rating from the analyst consensus, with 3 recent Buy reviews and 1 Hold. Shares have an average price target of $15.67, which is almost flat compared to the current trading price. The real return here is in the dividend. (See CSWC stock analysis at TipRanks)

  • Why 5 U.S. Cannabis Stocks Will Outperform Amid Federal Ban

    Lower-valued American cannabis stocks are set to outperform their Canadian rivals as U.S. legal pot sales outpace those north of the border.

  • Can Nio's Q3 Earnings Reignite The Rally Cut Short By Citron's Warning?

    Nio Inc's (NYSE: NIO) scintillating rally came to a screeching halt Friday after short seller Citron Research spoiled the party by suggesting the EV maker's astronomical valuation becomes unjustifiable.Nio's Rally and The Hard Fall: Nio's stock, which ended 2019 at $4.02, began to turn the corner along with the post-COVID recovery in deliveries. The rally picked up steam amid the company's conscientious efforts to innovate, cut the flab and work further on its service-focused approach.Ahead of Friday's session, the stock was up about 1,100% compared to Tesla Inc's (NASDAQ: TSLA) 392% advance.Nio started Friday's session on a strong note, thanks to strong quarterly results reported by domestic peer Li Auto Inc. (NASDAQ: LI), and went on to hit a high of $54.20. It took just six sessions for the stock to move from $40 to $50.However, shares came under heavy selling pressure following Citron's report in which the firm gave Nio's stock a $25 price target. After being down about 16% at one point in the session, the stock has cut its losses to some extent to close down 7.7% at $44.56.Related Link: Nio, Li Auto Make Big Moves Following Xpeng's Q3 ResultsIs There Merit To Citron's Argument? Citron harped on Nio losing out on market share due to Tesla pricing, especially the "Made In China" Model Y, competitively. The U.S. EV giant's price cuts undoubtedly can hurt.However, Nio has carved a niche for itself with its technological prowess and service-focused approach to lure customers.After unveiling a 100-kilowatt-hour battery recently, the company is reportedly working on 150 kWh battery, which can nearly double the range of its EVs. According to reports, the company is also working on developing in-house chips for its ADAS system.The company has managed to up its mindshare among consumers."Compelling evidence exists that consumers are increasingly perceiving Nio as a 'high-quality premium brand' with best-in-class technology and service," Deutsche Bank analyst Edison Yu said in a late September note.The company has made its cars affordable by introducing the Battery-as-a-Service scheme, which trims a significant amount from the list price.Nio is also eyeing global expansion and is reportedly building a separate team to work on the roadmap for exporting vehicles to Europe.Can Earnings Salvage The Stock? Nio is scheduled to report its fiscal-year third-quarter results next Tuesday before the market open. Analysts, on average, estimate a loss of 17 cents per share on revenues of $652.77 million.This represents a marked improvement from the loss of $2.38 per share and revenues of $262.47 million reported for the year-ago quarter.Nio's third-quarter deliveries jumped over 150% year-over-year to 12,206, marking a quarterly record. The strong momentum continued into October, with the company reporting a 100% increase in deliveries to a record of 5,055 units for the month.Valuation Stretched? The run-up seen since the second quarter has rendered Nio's valuation unattractive and unsustainable. For that matter, most EV stocks are showing frothiness and are in bubble territory.That said, Nio has shown discipline and proactiveness in improving its fundamentals and is operating in the sweet spot of a booming Chinese EV market.Fundamental performance in the months ahead will serve as a key to the stock's trajectory.See more from Benzinga * Click here for options trades from Benzinga * Nio, Li Auto Make Big Moves Following Xpeng's Q3 Results * Nio Unveils 100-kWh Battery, Upgrade Plans: What Investors Should Know(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • These Are The 5 Best Stocks To Buy And Watch Now

    Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?

  • Tesla Gigafactory Texas Progress Revealed In Aerial Photos

    Tesla Inc (NASDAQ: TSLA) is currently building Gigafactory Texas, which will build Tesla's Cybertruck, Model 3, Y and possibly more.New drone pictures show the progress being made on the factory. The photographer notes in a video some of the many changes observed at the site.> Here are a few more photos from 12 November Giga Texas ... a lot going on all over the work site! Check out my YouTube Video (@JoeTegtmeyer) later today for a lot more and information on what is going on at the site! pic.twitter.com/M75jzDNTnq> > -- Joe Tegtmeyer (@JoeTegtmeyer) November 12, 2020We're starting to see many structures begin to take shape. Most of the massive expanse of land is prepped, including more permanent working areas and plenty of gravel and backfill for future construction. Tesla plans to begin deliveries of the Cybertruck by the end of 2021.Photo courtesy of TeslaSee more from Benzinga * Click here for options trades from Benzinga * Tesla Gigafactory Shanghai Production Rate Points To Sharp Annual Increase * Waymo Suggests 'Orders Of Magnitude More Advanced' Than Tesla's Full Self-Driving Approach(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • This Petty Squabble Is Your Big Chance to Load up on Alibaba Stock

    A couple of weeks ago, I wrote about how Alibaba (NYSE:BABA) had three major catalysts on the horizon. I thought Alibaba stock was a good buy at the time.  Source: Kevin Chen Photography / Shutterstock.com The good news for Alibaba investors is that two of those three catalysts have worked out well. The bad news is that the third has been an unmitigated disaster.  Jack Ma and the Chinese Communist Party (CCP) have totally botched the Ant Financial IPO. Fortunately for Alibaba investors, the market has completely overreacted to the news. InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Ant-related Alibaba sell-off is a great buying opportunity for long-term investors. And it’s in China’s best interest to demonstrate to the world they can trust Chinese investments. Bullish Catalysts for Alibaba Stock Let’s discuss the good news for Alibaba first. Joe Biden won the US election. More importantly for Alibaba investors, Donald Trump lost the election. 7 Retail Stocks That Will Benefit From 2020’s Holiday Shopping Season Trump made his trade war with China one of the centerpieces of his administration. His animosity toward China coupled with his unpredictability created a cloud of uncertainty for Chinese stocks like Alibaba for four years. It doesn’t even matter whether or not Biden will be “soft” on China. Getting Trump out of the White House is bullish for Alibaba and other Chinese stocks. The next bullish catalyst in the past couple of weeks was Alibaba’s third-quarter earnings. The company reported non-GAAP diluted earnings per share of $4.83 in the most recent quarter, topping consensus analyst estimates of $2.08. Revenue for the quarter was up 30% to $22.83 billion, slightly missing analyst estimates of $23.19 billion. Alibaba’s cloud revenue was up 60%, far surpassing the growth rates of US cloud leaders Amazon (NASDAQ:AMZN) and Microsoft (NASDAQ:MSFT). The cherry on top of a strong quarter for Alibaba was its blowout Singles’ Day numbers. This week, Alibaba reported a record $74.1 billion in Singles’ Day gross merchandise value, nearly double last year’s $38 billion in sales. For perspective, Alibaba generated about seven times the $10.4 billion Amazon generated during its 48-hour Prime Day sales event this year.  Ant IPO Debacle Despite all the good things mentioned above that should have a positive impact on the Alibaba stock price and its long-term business outlook, the stock has taken a major beating in the past couple of weeks. It all started with Jack Ma opening his mouth. Jack Ma was a co-founder of Alibaba and the founder of Ant Group, which is 33% owned by Alibaba.  Prior to the Ant IPO, Ma said in a speech that Chinese banks operate with a “pawnshop mentality.” First, most major Chinese banks are state-owned. In China, the “state” is the CCP, of which Ma is a member. But Ma apparently decided to criticize the CCP just days before the Ant IPO, which was on track to be the biggest in the history of the world.  Ma should have known better. The CCP responded by announcing brand new rules on micro-lending in China and promptly pulling the Ant IPO when the company didn’t immediately comply with those rules. The CCP then followed up by proposing new antitrust regulations that could impact pricing, payment methods and data used by Chinese tech companies. The Chinese government felt Ma was out of line with his comments. Ma made a power play with his criticism, and the CCP felt they needed to put him and other Chinese tech entrepreneurs in their place. But this petty power drama has already wiped more than $280 billion in value from Chinese tech companies, including Alibaba. It has also further tarnished the already pretty horrible reputation Chinese stocks have on the global market.  The CCP should have known better. What It Means for Alibaba Stock At the end of the day, I believe this political bickering in China won’t result in many major disruptions to Alibaba’s business. It’s not in China’s best interest to cripple some of its biggest economic growth engines. At the same time, Ant Group’s reputation has been tarnished, and new regulations could have a significant impact on its business.  The Patriarch Organization estimates Ant’s valuation could drop from around $300 billion to $150 billion by the time it goes public, likely in 2021. In other words, the value of Alibaba’s 33% stake could drop by $50 billion. Fortunately for Alibaba investors, the company’s market cap is already down by more than $120 billion so far in  November. In other words, Alibaba stock seems to be pricing in that Ant is now worthless. Of course, that idea is ridiculous considering Ant is China’s largest digital payment platform.  All this drama surrounding Ant, Ma and the CCP will ultimately blow over. It’s in all parties’ best interest for Ant, Alibaba and China to succeed on the world stage. In the meantime, I agree with Jim Cramer’s take on the Alibaba sell-off.  “I am pounding the table to buy Alibaba.” On the date of publication, Wayne Duggan held a long position in BABA. Wayne Duggan has been a U.S. News & World Report Investing contributor since 2016 and is a staff writer at Benzinga, where he has written more than 7,000 articles. He is the author of the book “Beating Wall Street With Common Sense,” which focuses on investing psychology and practical strategies to outperform the stock market. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets The post This Petty Squabble Is Your Big Chance to Load up on Alibaba Stock appeared first on InvestorPlace.

  • Stock Market Rally At Highs, With Google, JD.com, Moderna Coronavirus Vaccine In Focus; What You Should By Monday

    The stock market is at highs, but which sectors will lead? Google is in a rare stock in buy zone now. JD.com earnings and Moderna coronavirus vaccine news loom.

  • How celebrities use mortgages to build wealth (and you can, too)

    A home loan is a powerful financial tool, even if you have the cash to pay outright.

  • Reasons Your Social Security Check Was Short This Month

    If you recently started receiving Social Security benefits, here are some reasons why you may be getting less than you expected.

  • Why It Might Be Time To Pay Attention To These 4 Red-Hot Health Stocks

    The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.

  • 2 “Strong Buy” Penny Stocks With Massive Upside Potential Ahead

    There is a clear conclusion to be reached from the US election results – the American people wanted to discard the drama of both President Trump and Democratic Party, and are willing to do so by installing a Democratic President while increasing Republican strength in Congress and down ballot. A result like that points to future gridlock, at least in the near-term, and that in turn could be just what that markets want. A deeply divided government is unlikely to make any drastic policy changes, to the right or to the left, allowing the financial world to keep plodding straight along.Which means, we may be near a bottom for many stocks with depressed share values. If so, this effect may be most visible among the so-called penny stocks, shares with a selling price below $5. These stocks are already close to the true bottom of the market, and basic statistics shows that they are more likely than not going to rise.However, before jumping right into an investment in a penny stock, Wall Street pros advise looking at the bigger picture and considering other factors beyond just the price tag. For some names that fall into this category, you really do get what you pay for, offering little in the way of long-term growth prospects thanks to weak fundamentals, recent headwinds or even large outstanding share counts.Taking the risk into consideration, we used TipRanks’ database to find compelling penny stocks with bargain price tags. The platform steered us towards two tickers sporting share prices under $5 and “Strong Buy” consensus ratings from the analyst community. Not to mention substantial upside potential is on the table.Sequans Communications (SQNS)Sequans Communications is a chipmaker, with a solid reputation in the 4G market and a forward-looking focus on the 5G and IoT sectors. The company has incorporated several generations of tech developments into its IoT chip designs, and become a leading innovator in that market.So far, the chaotic conditions of 2020 have not been easy for SQNS. The company has been hit hard by disruptions in the supply and distribution chains, and is down 48% since hitting its peak in July.On the plus side of the ledger, revenues rose – as they have been all year. The Q3 top line was $14.1 million, which represented a 15% sequential gain and an impressive increase of 116% year-over-year.Currently going for $4.09 apiece, Sequans shares could see major gains, according to some analysts.Covering the stock for Roth Capital, 5-star analyst Scott Searle points out the company’s upbeat potential: “Sequans continues to hit key customer and product development milestones. The places the company on track for samples in late 2021. Importantly, in addition the anticipated $10M 5G strategic opportunity, Sequans is actively engaged with several additional potential partners. We believe that the company remains uniquely positioned to become a tier 1 supplier into specialized 5G applications that we expect to represent 10’s of millions of units by the 2023-2025 time frame in terrestrial FWA, satellite, public safety, etc. We highlight that Ericsson continues to forecast FWA lines to increase from 51M in 2019 to 160M by 2025, representing a $500M to $1B TAM.”To this end, Searle rates SQNS a Buy along with a $13 price. Should his thesis play out, a potential gain of 218% could be in the cards. (To watch Searle’s track record, click here)Sequans holds a unanimous Strong Buy rating from the analyst consensus, based on 4 Buy reviews given in the last two months. Furthermore, the average price target suggests it will more than double, growing by 148% from current levels. (See SQNS stock analysis on TipRanks)Repro-Med Systems (KRMD)Next on the list, Repro-Med Systems, is a medical device company. This small cap company inhabits a competitive niche – but one with a high profit potential when new treatments or devices are approved. KRMD designs products for infusion therapies and emergency medicine, two vital segments of the medical market. The company operates under the name KORU Medical Systems.KRMD peaked this year in April, and has been losing ground in share value ever since. The stock is down 69%, even though revenues grew in 1H20. Results for the calendar third quarter were mixed; the top line slipped sequentially to just over $6 million, but cumulative sales for the first three quarters of 2020 are up 19% from the same period in 2019. Operating expenses have been stable, and gross profit totaled over 64% of net sales. The company finished the quarter with $32.4 million in net cash available.Kyle Rose, 5-star analyst with Canaccord, sees an opportunity here, especially for investors willing to shoulder some risk. He writes, “For investors that can play these smaller names we view this as a compelling buying opportunity. The headwinds in the Q3 are a near-term challenge but far from a long-term thesis changer. We continue to think investors will need to look past quarter/quarter volatility to ascertain longer-term annualized trends, which continue to look positive here. KRMD benefits from a persistent trend away from IV to SC Ig delivery and offers a compelling value proposition that positions the company to emerge as the standard of care for large volume subcutaneous drug delivery.”Acknowledging the headwinds, Rose rates KRMD a Buy along with a $10 price target. This figure suggests strong growth of 164% in the year ahead. (To watch Rose’s track record, click here)This is another stock with a unanimous Strong Buy from the analyst consensus. That rating is based on 3 Buy reviews, and points to Wall Street’s confidence. The average share price is $9.67, which indicates a 155% upside from the trading price of $3.83. (See KRMD stock analysis on TipRanks)To find good ideas for penny stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

  • Biden's 'noble' plan for Social Security wouldn't solve all funding problems

    As President-Elect Joe Biden prepares for his first year in office, he’ll have to grapple with the future funding problems facing Social Security and how to insure financial security for older Americans.

  • Is Pfizer Stock A Buy After Its Coronavirus Vaccine Proved 90% Effective?

    Pfizer stock jumped in early November after the pharma company's coronavirus vaccine proved 90% effective in a final-phase study. But if the pharmaceutical company's stock a buy now?

  • LinkedIn co-founder: These tweaks will make your job application stand out

    In a new interview with Yahoo Finance, LinkedIn co-founder Reid Hoffman shared three pieces of advice for job hunters seeking to stand out as millions of people apply for work online amid the coronavirus.

  • Cramer Gives His Opinion On Barrick Gold, Las Vegas Sands And More

    Jim Cramer said on CNBC's "Mad Money Lightning Round" he sees a terrific opportunity to buy gold or Barrick Gold Corp (NYSE: GOLD).Biden is going to have a better relationship with China than Trump did, so Las Vegas Sands Corp. (NYSE: LVS) is going to be fine to own, thinks Cramer. He prefers Wynn Resorts, Limited (NASDAQ: WYNN).The U.S. Defense Department does well under either administration, said Cramer. He prefers L3Harris Technologies Inc (NYSE: LHX) over Lockheed Martin Corporation (NYSE: LMT).Instead of Carnival Corp (NYSE: CCL), Cramer is recommending Norwegian Cruise Line Holdings Ltd (NYSE: NCLH).Cramer likes Vonage Holdings Corp. (NASDAQ: VG).Macerich Co (NYSE: MAC) is a speculative stock, Cramer said, and he is not a buyer. See more from Benzinga * Click here for options trades from Benzinga * 'Trading Nation' Analysts Share Their Picks(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.